Shares of Xos, Inc. (NASDAQ:XOS – Get Free Report) were down 2.7% on Friday . The stock traded as low as $4.73 and last traded at $4.74. Approximately 22,066 shares were traded during trading, an increase of 36% from the average daily volume of 16,237 shares. The stock had previously closed at $4.87.
Analysts Set New Price Targets
A number of research firms recently issued reports on XOS. Northland Securities reiterated an “outperform” rating and set a $9.00 price objective (down from $16.00) on shares of XOS in a report on Thursday, August 15th. DA Davidson downgraded shares of XOS from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $17.00 to $9.00 in a report on Friday, August 16th. Finally, Wedbush cut their price objective on shares of XOS from $15.00 to $12.00 and set an “outperform” rating on the stock in a research report on Thursday, August 15th.
XOS Stock Down 2.7 %
XOS (NASDAQ:XOS – Get Free Report) last posted its quarterly earnings results on Tuesday, August 13th. The company reported ($1.23) earnings per share for the quarter, topping the consensus estimate of ($2.27) by $1.04. The firm had revenue of $15.54 million for the quarter, compared to analyst estimates of $18.65 million. XOS had a negative return on equity of 84.60% and a negative net margin of 76.21%. On average, equities research analysts anticipate that Xos, Inc. will post -6.33 earnings per share for the current year.
About XOS
Xos, Inc designs, manufactures, and sells battery-electric commercial vehicles. The company provides class 5-6 medium duty rolling chassis, such as commercial stepvans and armored trucks; class 7-8 heavy duty chassis; and Xos product development. It offers Xos provides mix-use powertrain solutions for off-highway, industrial and other commercial equipment, and specialty vehicles, such as school buses, medical and dental clinics, blood donation vehicles, and mobile command vehicles.
Featured Stories
- Five stocks we like better than XOS
- How to invest in marijuana stocks in 7 stepsĀ
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- What is a SEC Filing?
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for XOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOS and related companies with MarketBeat.com's FREE daily email newsletter.